Portfolio Leader, Oncology & Rare Disease – Middle East

Pfizer; Dubai; On-site; AED 350,000 - 750,000; Full time

Job summary

Pfizer is seeking a Category Lead for Oncology & Rare Disease – Middle East, based in Dubai. You will translate enterprise priorities into portfolio, brand and market strategies, steering end-to-end planning and investments to balance growth with patient impact.

You will lead cross-functional teams across Regulatory, Medical, Access, Policy, Supply and Finance, ensuring launch readiness and lifecycle management for in-line assets and future launches.

Qualifications

• Bachelor’s degree in Life Sciences, Pharmacy, Medicine, Business or a related field.
• An MBA or equivalent advanced degree is preferred.
• At least 10 years of pharmaceutical or healthcare experience, including substantial commercial leadership responsibility.
• Demonstrated success leading complex portfolios, major launches and cross-functional teams in a matrix environment.
• Experience in Oncology, Rare Disease, Specialty Care or another complex specialty portfolio is strongly preferred.
• Strong commercial and financial acumen, including P&L management, forecasting, investment decisions and portfolio prioritization.
• Deep understanding of specialized clinical pathways, diagnostics, patient journeys and complex access environments.
• Proven people leadership, with direct accountability for talent development, succession and team performance.
• Ability to integrate Commercial, Medical, Access & Value, Regulatory, Supply, Finance, Legal, Compliance and regional or global perspectives into practical business decisions.
• Strong external orientation and the ability to convert customer, patient, competitor and health-system insights into action.
• Enterprise mindset and the ability to influence senior stakeholders across cultures, markets, functions and organizational levels.
• Excellent analytical, strategic, communication and executive-presentation skills.
• Fluent English is required.
• Arabic language capability is an advantage.

Responsibilities

• Translate the Middle East Oncology and Rare Disease strategy into clear portfolio, brand, market and customer priorities aligned with the cluster operating plan and growth agenda.
• Lead end-to-end portfolio planning across in-line brands, new indications, pipeline assets and future launches, balancing current performance with long-term category value.
• Shape differentiated strategies that reflect local disease burden, clinical pathways, diagnostic requirements, patient needs, access conditions and competitive dynamics.
• Establish category governance, operating rhythms and performance reviews that connect enterprise and regional strategy with market execution.
• Make disciplined portfolio trade-offs and direct resources toward the highest-value opportunities for patients and the business.
• Own category performance, providing clear direction on revenue, profitability, market share, investment and resource deployment.
• Lead annual operating and long-range planning for the Oncology and Rare Disease portfolio, ensuring robust assumptions, scenarios, risk assessment and growth choices.
• Prioritize approved marketing and commercial investments across brands, launches and markets, reallocating resources to the highest-impact opportunities.
• Monitor performance and intervene early when launch, demand, access, supply or execution risks threaten category objectives.
• Use performance data, market intelligence and customer insights to accelerate decisions and strengthen execution.
• Lead integrated launch strategy and readiness for new products, indications and presentations across Middle East markets.
• Define launch ambition, sequencing, market archetypes, customer strategy, investment requirements and critical success factors.
• Build integrated launch plans across Regulatory, Medical, Access & Value, Policy & Public Affairs, Supply, Marketing, Sales and customer engagement.
• Track readiness and post-launch performance through clear milestones and governance, accelerating decisions and removing execution barriers.
• Optimize lifecycle strategies for in-line assets to sustain growth, expand patient reach and maximize portfolio value.
• Identify barriers across awareness, diagnosis, referral, treatment initiation, monitoring and continuity of care.
• Translate patient and healthcare-system insights into compliant, cross-functional priorities and solutions.
• Sponsor initiatives that strengthen diagnostic pathways, specialist networks and coordinated care.
• Ensure category strategies reflect the needs of patients, caregivers, healthcare professionals and health-system stakeholders.
• Define measurable outcomes for priority patient-journey and ecosystem initiatives.

Skills

Fluent English

Analytical skills

Strategic thinking

Executive communication

Leadership

Education

Bachelor’s degree in Life Sciences/Pharmacy/Medicine/Business

MBA or equivalent advanced degree

Job description

Pfizer is seeking a Category Lead for Oncology & Rare Disease – Middle East, based in Dubai. You will translate enterprise priorities into portfolio, brand and market strategies, steering end-to-end planning and investments to balance growth with patient impact.

You will lead cross-functional teams across Regulatory, Medical, Access, Policy, Supply and Finance, ensuring launch readiness and lifecycle management for in-line assets and future launches.